anagrelide hydrochloride
anagrelide hydrochloride is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Agrylin. Available dosage forms: powder, capsule.
Drug Details
- Generic Name
- anagrelide hydrochloride
- Brand Names
- Agrylin
- Application Number
- NDA020333
- Sponsor
- Zydus Lifesciences Limited
- NDC Codes
- 2
- Dosage Forms
- POWDER, CAPSULE
- Routes
- ORAL
- Active Ingredients
- ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE ANHYDROUS
Indications and Usage
1 INDICATIONS AND USAGE AGRYLIN is indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. AGRYLIN is a platelet reducing agent indicated for the treatment of thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. ( 1 )